✦ LIBER ✦

Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD)

✍ Scribed by G. BOUMA; B. XIA; J. B. A. CRUSIUS; G. BIOQUE; I. KOUTROUBAKIS; B. M. E. VON BLOMBERG; S. G. M. MEUWISSEN; A. S. PEÑA

Book ID: 108698646
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 827 KB
Volume: 103
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.1996.tb08292.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms of tumor necrosis factor (

Polymorphisms of tumor necrosis factor (TNF) α and β genes in Korean patients with psoriasis

✍ Tai-Gyu Kim; Chul-Woo Pyo; Sung-Suk Hur; Yang-Kyum Kim; Ha-Young Hwang; Jai-Il Y 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 176 KB

European guidelines for the use of anti-

European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease

✍ Wolfgang Kruis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 13 KB

Tumour necrosis factor-α receptor 1 and

Tumour necrosis factor-α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

✍ M. Pierik; S. Vermeire; K. V. Steen; S. Joossens; G. Claessens; R. Vlietinck; P. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Association of vitamin D receptor gene p

Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease

✍ Nosratollah Naderi; Alma Farnood; Manijeh Habibi; Faramarz Derakhshan; Hedieh Ba 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

Distribution of peroxisome proliferator–

Distribution of peroxisome proliferator–activated receptor–gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease

✍ Umid Kumar Shrestha; Ouafae Karimi; J. Bart A. Crusius; Feng Zhou; Zhongli Wang; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Background: As peroxisome proliferator-activated receptor-gamma (ppar-gamma) is frequently expressed in colon, its genetic polymorphism may play a role in the etiology of inflammatory bowel disease (ibd). the aims of the present study were to determine the distribution of ppar-gamma polymorphism

The safety profile of anti-tumour necros

The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up

✍ C. W. LEES; A. I. ALI; A. I. THOMPSON; G.-T. HO; R. O. FORSYTHE; L. MARQUEZ; C. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB